Ashish Bhuta Board of Director Membership

Home

Insights

Ashish Bhuta Board Membership

Last Updated on: Nov 23, 2024

About Ashish Bhuta

Shri Ashish Bhuta, aged 50, holds a Bachelor of Commerce degree, a Master’s in Finance Management, and a postgraduate diploma in Patent Law & Practice.
He has received recognition for his achievements, including coordinating the commissioning of the Sihor Plant, leading the team to obtain ISO 9002 and WHO GMP certifications, and establishing a government-approved R&D unit, which garnered two National Awards from ICWAI. He exercises substantial executive power and is responsible for the overall operations of the company, managing core functional departments such as finance, marketing, and human resources.
As of March 31, 2023, he holds 261,127 equity shares in the company and received a remuneration of ₹200.54 Lacs for the fiscal year 2022-23.
His recent initiatives include the creation of a Wellness department, showcasing his commitment to innovation and operational excellence within Jenburkt Pharmaceuticals Ltd.

List of Companies Associated with Ashish Bhuta

Company Name	Position Held	Market Cap	Sector	Date Of Appointment

Jenburkt Pharmaceuticals Ltd

Chairman & Managing Director

447.13

Pharmaceuticals

Mar, 2015

Company Name	Position Held
Jenburkt Pharmaceuticals Ltd	Chairman & Managing Director

PRICE

<p>The current market price or CMP refers to the price of those companies associated with Ashish Bhuta at which the securities are trading in the share market.</p> <br> <h2>Current price in Over-the-counter costs:</h2> <p>The following current price of those companies associated with Ashish Bhuta depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC).</p> <br> <h2>Current Price in Bond Market: </h2> <p>The current price of a bond of those companies associated with Ashish Bhuta is determined by measuring the actual interest rate against the bid-related interest rate.</p> <br> <p>The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.</p>

Historical Share prices

* All values are in Rupees

Ashish Bhuta Sector Specific Experience

About Ashish Bhuta's work experience

Ashish Bhuta is currently a Chairman & Managing Director in Jenburkt Pharmaceuticals Ltd (as of Mar 2024).
Ashish Bhuta is serving the company - Jenburkt Pharmaceuticals Ltd at this position since 2015 for the last 10+ years.
Prior to becoming Chairman & Managing Director, Ashish Bhuta was Additional Director of Aro Granite Industries Ltd for 1 year in 2023.

FAQ's related Ashish Bhuta

Who is Ashish Bhuta

Shri Ashish Bhuta, aged 50, holds a Bachelor of Commerce degree, a Master’s in Finance Management, and a postgraduate diploma in Patent Law & Practice. He has received recognition for his achievements, including coordinating the commissioning of the Sihor Plant, leading the team to obtain ISO 9002 and WHO GMP certifications, and establishing a government-approved R&D unit, which garnered two National Awards from ICWAI. He exercises substantial executive power and is responsible for the overall operations of the company, managing core functional departments such as finance, marketing, and human resources. As of March 31, 2023, he holds 261,127 equity shares in the company and received a remuneration of ₹200.54 Lacs for the fiscal year 2022-23. His recent initiatives include the creation of a Wellness department, showcasing his commitment to innovation and operational excellence within Jenburkt Pharmaceuticals Ltd.

Which companies does Ashish Bhuta serve as a board member for?

Ashish Bhuta serves as a board member for: Jenburkt Pharmaceuticals Ltd,Aro Granite Industries Ltd

What positions has Ashish Bhuta held in his/her career?

Throughout their career, Ashish Bhuta has held key positions such as Chairman & Managing Director,Additional Director, contributing to the growth and success of each company.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*